PATENT CLAIM ANALYSIS

Application Number: 16002441
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "575000"]

Abstract:
The present invention includes compositions for treating cancer, and methods using same. In certain embodiments, the compositions of the invention comprise a histone deacetylase inhibitor (HDACi), a cyclodextrin, water, optionally a polyalkylene glycol, and optionally dimethyl sulfoxide (DMSO). In other embodiments, the compositions of the invention comprise a HDACi, a cyclodextrin, water, a polyalkylene glycol, and DMSO.

Claim (Index 11):
The method of  claim 1 , wherein the polyalkylene glycol is at least one selected from the group consisting of polyethylene glycol, polypropylene glycol, and any mixtures thereof.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 94.0
- Lexical Diversity: 2.08333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14737473', '15813582', '14451928', '15128977', '15998610']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7785651436557338
- 35 USC 102 Novelty (BERT): 0.5011757696344986
- Combined Prediction Score: 0.7508262062536103
- Mean Citation Score: 214.736758
- Max Citation Score: 246.10732
- Similarity Product: 172.2298374328899

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test